Correspondence 0001193125-26-009088 from CERENOME, INC. (PSTV)
CERENOME, INC.
Date: Jan. 9, 2026 · CIK: 0001095981 · Accession: 0001193125-26-009088
AI Filing Summary & Sentiment
File numbers found in text: 333-292637
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 9, 2026 VIA EDGAR TRANSMISSION Division of Corporate Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-6010 Re: Plus Therapeutics, Inc. Registration Statement on Form S-1 (Registration No. 333-292637) Request for Acceleration of Effective Date Ladies and gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), Lake Street Capital Markets, LLC, as underwriter, hereby joins Plus Therapeutics, Inc. in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-292637) to become effective on January 13, 2026 at 5:00 p.m., Eastern Time, or as soon as practicable thereafter. Pursuant to Rule 460 under the Act, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus prior to the requested effective time of the Registration Statement. Very truly yours, LAKE STREET CAPITAL MARKETS, LLC By: /s/ Michael Townley Name: Michael Townley Title: Head of Investment Banking cc: Jonathan Zimmerman, Esq., Faegre Drinker Biddle & Reath LLP